ReferIndia News 'Health Risk': Novo Nordisk Sues Hims & Hers Over Cheaper Version Of Ozempic, Wegovy Fat Loss Pills

ReferIndia News

Need a stunning portfolio website?

ReferIndia is your one-stop solution for design, development, and deployment—fast and professional!

Create Now
News Image

'Health Risk': Novo Nordisk Sues Hims & Hers Over Cheaper Version Of Ozempic, Wegovy Fat Loss Pills

Published on: Feb. 9, 2026, 7:31 p.m. | Source: NDTV Profit

Hims had planned to sell the drug at a sharply discounted price of $49 for the first month, which is almost $100 less than Novo's approved Wegovy pill.

Checkout more news
Ad Banner

🧠 AI की ताक़त से तैयार करें प्रोफेशनल वेबसाइट — स

कोई कोडिंग नहीं, कोई टेक्निकल झंझट नहीं — अपने बिज़नेस को आज ही डिजिटल दुनिया से जोड़ें

Start Now
ReferIndia News contact